Showing 1791-1800 of 2813 results for "".
- Curtis Cluff Named President and CFO of BioPhotas Inc.https://modernaesthetics.com/news/curtis-cluff-named-president-and-cfo-of-biophotas-inc/2473313/Curtis Cluff is the new President and Chief Financial Officer BioPhotas Inc., manufacturers of the Celluma series of light therapy devices. In this newly created role, Mr. Cluff will report to Patrick Johnson, Chief Executive Officer and inventor of the Celluma. &quo
- Galderma Gives Back: Brand Partners with NBCF to Launch Campaign Elevating Skin Stories of Breast Cancer Survivorshttps://modernaesthetics.com/news/galderma-gives-back-brand-partners-with-nbcf-to-launch-campaign-elevating-skin-stories-of-breast-cancer-survivors/2473307/Galderma is continuing its partnership with National Breast Cancer Foundation Inc. (NBCF) with a new campaign that elevates the skin stories of breast cancer survivors. Galderma is featuring the personal stories and treatment journeys of breast cancer survivors who receivedRestylan
- Sientra Gives Back: Company Launches Several Breast Cancer Awareness Initiativeshttps://modernaesthetics.com/news/sientra-gives-back-company-launches-several-breast-cancer-awareness-initiatives/2473306/Sientra is launching several initiatives in honor of Breast Cancer Awareness Month. Sientra has partnered with actress and breast cancer survivor, Miranda McKeon; collaborated with the Brem Foundation to launch “Sientra Supports”; and continues to support Re
- L'Oréal USA to Open New Research & Innovation Center in New Jerseyhttps://modernaesthetics.com/news/loreal-usa-to-open-new-research-innovation-center-in-new-jersey/2473305/L'Oréal USA is opening a new, state-of-the-art Research & Innovation (R&I) Center in Clark, New Jersey, replacing its existing facilities that it has occupied in the area for more than six decades. The $140 million development project represents the most significant investment
- BuildMyHealth Names First Chief Revenue Officerhttps://modernaesthetics.com/news/buildmyhealth-points-first-chief-revenue-officer/2473302/BuildMyHealth, developer of the No Surprises Act price transparency and lead conversion platform, has its first Chief Revenue Officer. Chad Sawyer was previously a national sales executive with both Crystal Clear Digital Marketing and Patient Now. In those roles, Mr. Sawyer helped hundreds of pra
- Allergan Aesthetics and BOTOX Cosmetic Reveal New 'See Yourself' Campaign Casthttps://modernaesthetics.com/news/allergan-aesthetics-and-botox-cosmetic-reveal-new-see-yourself-campaign-cast/2473299/Allergan Aesthetics is unveiling the 25 real patients – of all forms, genders, ethnicities and backgrounds – who were selected to participate in the latest iteration of the BOTOX Cosmetic 'See Yourself' campaign. After receiving nearly 20,000 submissions t
- CARE Curriculum Launched by DREAM Initiative from Allergan Aesthetics, SkinBetter Sciencehttps://modernaesthetics.com/news/care-curriculum-launched-by-dream-initiative-from-allergan-aesthetics-skinbetter-science/2473296/The DREAM Initiative®, developed by Allergan Aesthetics and skinbetter science®, has supported the development of a racial equity curriculum for dermatology residency programs. The Curriculum f
- Allergan Aesthetics Celebrates 100 Million Syringes of JUVÉDERMhttps://modernaesthetics.com/news/allergan-aesthetics-celebrates-100-million-syringes-of-juvederm/2473294/Drumroll, please…Allergan Aesthetics, an AbbVie company, has produced and shipped 100 million syringes of JUVÉDERM products globally. Since its launch in 2000, the JUVÉDERM Collection of Fillers has grown to where its products are now available in mo
- Physician Growth Partners Advises on Women's Health Partnership in Chicagohttps://modernaesthetics.com/news/physician-growth-partners-advises-on-womens-health-partnership-in-chicago/2473293/Through a new partnership, Together Women’s Health, a portfolio company of Shore Capital Partners, has entered into the Chicago market and will empower The Northwestern Specialists for Women with significant resources to continue its growth.
- FDA Grants 510(k)Clearance to LASEROPTEK's HELIOS IV-785 for Aesthetic and Medical Dermatology Usehttps://modernaesthetics.com/news/fda-grants-510kclearance-to-laseropteks-helios-iv-785-for-aesthetic-and-medical-dermatology-use/2473291/The U.S. Food and Drug Administration has granted 510(k) clearance to LASEROPTEK Co., Ltd.’s HELIOS IV-785 laser system for aesthetic and medical dermatology applications. HELIOS IV-785's novel and synergistic combination of 785nm picosecond photoacoustic effect and 1064 &